Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)

NCT02171988 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Postural Orthostatic Tachycardia Syndrome

Interventions

DRUG: Propranolol
DRUG: Bisoprolol
DRUG: Propranolol+pyridostigmine
DRUG: Bisoprolol+pyridostgmine

Sponsor

Seoul National University Hospital